The 2023 European Lung Cancer Congress (ELCC) proved to be a momentous event, bringing together global experts in thoracic oncology. Organized jointly by the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO), the conference served as an annual update on the latest developments in the diagnosis and treatment of various thoracic tumors.In our interview, Dr. Martin Reck, the specialist in pulmonology from Lung Clinic Grosshansdorf, shared insights into the conference’s themes and highlighted significant studies that shed light on targeted therapies and immunotherapy.